Correlation Between Gemina Laboratories and Sartorius Aktiengesellscha

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gemina Laboratories and Sartorius Aktiengesellscha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gemina Laboratories and Sartorius Aktiengesellscha into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gemina Laboratories and Sartorius Aktiengesellschaft, you can compare the effects of market volatilities on Gemina Laboratories and Sartorius Aktiengesellscha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gemina Laboratories with a short position of Sartorius Aktiengesellscha. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gemina Laboratories and Sartorius Aktiengesellscha.

Diversification Opportunities for Gemina Laboratories and Sartorius Aktiengesellscha

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gemina and Sartorius is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Gemina Laboratories and Sartorius Aktiengesellschaft in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Aktiengesellscha and Gemina Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gemina Laboratories are associated (or correlated) with Sartorius Aktiengesellscha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Aktiengesellscha has no effect on the direction of Gemina Laboratories i.e., Gemina Laboratories and Sartorius Aktiengesellscha go up and down completely randomly.

Pair Corralation between Gemina Laboratories and Sartorius Aktiengesellscha

Assuming the 90 days horizon Gemina Laboratories is expected to generate 3.34 times more return on investment than Sartorius Aktiengesellscha. However, Gemina Laboratories is 3.34 times more volatile than Sartorius Aktiengesellschaft. It trades about 0.05 of its potential returns per unit of risk. Sartorius Aktiengesellschaft is currently generating about -0.09 per unit of risk. If you would invest  34.00  in Gemina Laboratories on September 26, 2024 and sell it today you would earn a total of  3.00  from holding Gemina Laboratories or generate 8.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Gemina Laboratories  vs.  Sartorius Aktiengesellschaft

 Performance 
       Timeline  
Gemina Laboratories 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Gemina Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, Gemina Laboratories reported solid returns over the last few months and may actually be approaching a breakup point.
Sartorius Aktiengesellscha 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Gemina Laboratories and Sartorius Aktiengesellscha Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gemina Laboratories and Sartorius Aktiengesellscha

The main advantage of trading using opposite Gemina Laboratories and Sartorius Aktiengesellscha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gemina Laboratories position performs unexpectedly, Sartorius Aktiengesellscha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Aktiengesellscha will offset losses from the drop in Sartorius Aktiengesellscha's long position.
The idea behind Gemina Laboratories and Sartorius Aktiengesellschaft pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments